Advertisement
Advances in Brief

Thromboxane A2 Is a Mediator of Cyclooxygenase-2-dependent Endothelial Migration and Angiogenesis

Thomas O. Daniel, Hua Liu, Jason D. Morrow, Brenda C. Crews and Lawrence J. Marnett
DOI:  Published September 1999

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2001 to January 2021

AbstractFull-text HTMLPDF
Total193245052759

Cited By

Article Information

Volume 59, Issue 18, pp. 4574-4577

PubMed 
10493510
Published By 
American Association for Cancer Research
Print ISSN 
0008-5472
Online ISSN 
1538-7445
History 
  • Received May 21, 1999
  • Accepted August 2, 1999
  • Published first September 1, 1999.
Copyright & Usage 
©1999 American Association for Cancer Research.

Author Information

  1. Thomas O. Daniel2,
  2. Hua Liu,
  3. Jason D. Morrow,
  4. Brenda C. Crews, and
  5. Lawrence J. Marnett
  1. Departments of Medicine, Cell Biology, Biochemistry, and Pharmacology, Divisions of Nephrology and Hypertension and Clinical Pharmacology, The Vanderbilt Center for Vascular Biology, Vanderbilt Cancer Center, Vanderbilt University, Nashville, Tennessee 3723
View Full Text
Back to top
September 1999
Volume 59, Issue 18

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Email Article
Citation Tools
Thromboxane A2 Is a Mediator of Cyclooxygenase-2-dependent Endothelial Migration and Angiogenesis
Thomas O. Daniel, Hua Liu, Jason D. Morrow, Brenda C. Crews and Lawrence J. Marnett
Cancer Res September 15 1999 (59) (18) 4574-4577;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement